Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases
Treatment of early relapses of T lymphoblastic leukemia/lymphoma is often unsuccessful. We tested an experimental regimen containing daratumumab and nelarabine in two young patients with early relapses of T lymphoblastic lymphoma and T-ALL, respectively. Both patients achieved a deep complete remiss...
Saved in:
Main Authors: | Ingolf Molle, Irma Petruskevicius, Peter Kamper, Francesco d’Amore |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2022/9722787 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
by: Lauren Elreda, et al.
Published: (2014-01-01) -
A Unique Case of Relapsed B-Acute Lymphoblastic Leukemia/Lymphoma as an Isolated Omental Mass
by: Kanchan Kantekure, et al.
Published: (2014-01-01) -
Relapsed Acute Lymphoblastic Leukemia Presenting as Acute Renal Failure
by: Ashley Rose, et al.
Published: (2019-01-01) -
Short‐Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study
by: Jin Yin, et al.
Published: (2024-12-01) -
Epstein–Barr Virus Driven Hodgkin’s Lymphoma after a Short Course of Daratumumab Treatment for Relapsed Multiple Myeloma
by: Moeen Mohammadi-Oroujeh, et al.
Published: (2023-01-01)